Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $141.4b | $515.28 | 0.0% | 19 |
 REGN | Regeneron Pharmaceuticals Inc | $86.8b | $773.08 | 0.0% | 51 |
 INSM | Insmed, Inc. | $27.7b | $120.98 | 0.0% | 263 |
 BMRN | BioMarin Pharmaceuticals Inc | $13.0b | $64.57 | 0.0% | 117 |
 KRYS | Krystal Biotech, Inc. Common Stock | $10.9b | $336.60 | 0.0% | 357 |
 CRSP | CRISPR Therapeutics AG | $5.5b | $52.42 | 0.0% | 3.8K |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 QURE | uniQure N.V. | $3.1b | $43.24 | 0.0% | 55.7K |
 BEAM | Beam Therapeutics Inc. Common Stock | $3.0b | $23.38 | 0.0% | 2.8K |
 PGEN | Precigen, Inc. Common Stock | $2.6b | $6.95 | 0.0% | 2 |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $2.4b | $21.36 | 0.0% | 78 |
 VCEL | Vericel Corporation | $2.1b | $39.75 | 0.0% | 631 |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.8b | $5.04 | 0.0% | 19 |
 NTLA | Intellia Therapeutics, Inc | $1.8b | $11.43 | 0.0% | 4.2K |
 BLFS | BioLife Solutions Inc. | $1.8b | $36.51 | 0.0% | N/A |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.3b | $12.94 | 0.0% | 108 |
 SANA | Sana Biotechnology, Inc. Common Stock | $1.2b | $3.17 | 0.0% | 3.3K |
 SLDB | Solid Biosciences Inc. Common Stock | $1.1b | $8.37 | 0.0% | 201 |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.1b | $24.10 | 0.0% | 1.9K |
 DSGN | Design Therapeutics, Inc. Common Stock | $1.0b | $12.23 | 0.0% | N/A |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.8b | $13.75 | 0.0% | 360 |
 CYRX | CryoPort, Inc. Common Stock | $0.8b | $16.37 | 0.0% | 275 |
 NGNE | Neurogene, Inc. Common Stock | $0.8b | $33.67 | 0.0% | N/A |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $1.74 | 0.0% | 284 |
 PRME | Prime Medicine, Inc. Common Stock | $0.7b | $3.17 | 0.0% | 44 |
 RGNX | REGENXBIO Inc. | $0.6b | $7.89 | 0.0% | 180 |
 CABA | Cabaletta Bio, Inc. Common Stock | $0.6b | $2.58 | 0.0% | 2.4K |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $0.5b | $6.98 | 0.0% | N/A |
 EDIT | Editas Medicine, Inc. Common Stock | $473.0m | $2.75 | 0.0% | 23 |
 OCGN | Ocugen, Inc. Common Stock | $457.8m | $1.00 | 0.0% | 1.7K |
 BNTC | Benitec Biopharma Inc. Common Stock | $442.5m | $11.05 | 0.0% | N/A |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $416.0m | $3.67 | 0.0% | 14.3K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $392.2m | $4.13 | 0.0% | 1 |
 IRD | Opus Genetics, Inc. Common Stock | $370.2m | $5.89 | 0.0% | 1.8K |
 ABEO | Abeona Therapeutics Inc. Common Stock | $340.2m | $5.51 | 0.0% | N/A |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $279.2m | $6.72 | 0.0% | N/A |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $208.3m | $3.10 | 0.0% | 1 |
 DTIL | Precision BioSciences, Inc. Common Stock | $205.6m | $6.62 | 0.0% | 28 |
 KRRO | Korro Bio, Inc. Common Stock | $176.3m | $14.35 | 0.0% | N/A |
 CRBU | Caribou Biosciences, Inc. Common Stock | $171.5m | $1.29 | 0.0% | 780 |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $155.9m | $0.68 | 0.0% | 351 |
 INO | Inovio Pharmaceuticals, Inc. | $140.6m | $1.17 | 0.0% | 421 |
 MXCT | MaxCyte, Inc. Common Stock | $130.0m | $1.18 | 0.0% | N/A |
 ENGN | enGene Therapeutics Inc. Common Stock | $126.6m | $1.90 | 0.0% | 668 |
 CBUS | Cibus, Inc. Class A Common Stock | $119.2m | $1.57 | 0.0% | N/A |
 GNLX | Genelux Corporation Common Stock | $115.4m | $2.50 | 0.0% | 8 |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 TIL | Instil Bio, Inc. Common Stock | $51.9m | $7.22 | 0.0% | N/A |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $43.8m | $1.18 | 0.0% | N/A |
 TCRX | TScan Therapeutics, Inc. Common Stock | $25.1m | $0.33 | 0.0% | 2.5K |